Home › Companies › ELEVANCE HEALTH INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and ELEVANCE HEALTH INC.’s Form 8-K, filed May 14, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 14, 2025: 6 items on ELEVANCE HEALTH INC.’s Form 8-K, filed May 14, 2025: 3 elected · 2 approved · 1 not approved.
No notable dissent.
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore ELEVANCE HEALTH INC. in the interactive database Compare manager voting policies
These tallies are ELEVANCE HEALTH INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 14, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Susan D. DeVore | 185,839,586 | 3,726,860 | 158,903 | -- | 11,942,703 | 98% | Elected | — |
| Elect Director: Bahija Jallal | 180,810,837 | 8,752,093 | 162,419 | -- | 11,942,703 | 95% | Elected | — |
| Elect Director: Ryan M. Schneider | 184,627,201 | 4,951,857 | 146,291 | -- | 11,942,703 | 97% | Elected | — |
| 2. Advisory vote on the Company's executive compensation | 173,964,580 | 15,522,459 | 238,310 | -- | 11,942,703 | 92% | Approved | — |
| 3. Ratification of the appointment of Ernst & Young LLP | 178,086,607 | 23,455,317 | 126,128 | -- | -- | 88% | Approved | — |
| 4. Shareholder proposal requesting report on the effectiveness of Diversity, Equity and Inclusion efforts | 26,240,205 | 160,685,853 | 2,799,291 | -- | 11,942,703 | 14% | Not approved | — |
Source: ELEVANCE HEALTH INC., Form 8-K, filed with the SEC on May 14, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
1,196 asset managers disclosed a vote on at least one ELEVANCE HEALTH INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 7 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Bahija Jallal
ELEVANCE HEALTH INC.’s own tally for this item (“Elect Director: Bahija Jallal”): 180,810,837 for, 8,752,093 against, per its Form 8-K filed May 14, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2028 based on the following votes:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 212 asset managers below reported 71,916,250 for, 1,738,896 against, 17,590 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 21,455,588 | 3 | 0 | 0 | For |
| BlackRock | 7,179,332 | 0 | 0 | 0 | For |
| Fidelity | 5,329,206 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,544,953 | 4,745 | 0 | 0 | For |
| Capital Group | 4,089,010 | 0 | 0 | 0 | For |
| State Street | 2,438,236 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 2,437,343 | 0 | 0 | 0 | For |
| MFS | 1,828,454 | 0 | 0 | 0 | For |
| Charles Schwab | 1,712,757 | 0 | 0 | 0 | For |
| Invesco | 0 | 1,555,935 | 0 | 0 | Against |
| Dimensional | 1,394,209 | 0 | 0 | 0 | For |
| TIAA | 1,382,693 | 0 | 0 | 0 | For |
| HARRIS ASSOCIATES INVESTMENT TRUST | 1,329,502 | 0 | 0 | 0 | For |
| Hartford | 1,197,678 | 198 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 1,144,770 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,080,718 | 0 | 0 | 0 | For |
| First Trust | 945,280 | 0 | 0 | 0 | For |
| John Hancock | 930,168 | 0 | 0 | 0 | For |
| GMO | 780,591 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 566,783 | 0 | 0 | 0 | For |
| AMCAP FUND | 523,858 | 0 | 0 | 0 | For |
| Victory Capital | 515,402 | 0 | 0 | 0 | For |
| Jackson National | 510,835 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 473,801 | 0 | 0 | 0 | For |
| JPMorgan | 466,391 | 0 | 0 | 0 | For |
Showing the 25 largest of 212 asset managers. All 212 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Ryan M. Schneider
ELEVANCE HEALTH INC.’s own tally for this item (“Elect Director: Ryan M. Schneider”): 184,627,201 for, 4,951,857 against, per its Form 8-K filed May 14, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2028 based on the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 212 asset managers below reported 73,602,584 for, 52,562 against, 17,589 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 21,455,590 | 2 | 0 | 0 | For |
| BlackRock | 7,179,332 | 0 | 0 | 0 | For |
| Fidelity | 5,329,206 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,544,953 | 4,745 | 0 | 0 | For |
| Capital Group | 4,089,010 | 0 | 0 | 0 | For |
| State Street | 2,438,236 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 2,437,343 | 0 | 0 | 0 | For |
| MFS | 1,828,454 | 0 | 0 | 0 | For |
| Charles Schwab | 1,712,757 | 0 | 0 | 0 | For |
| Invesco | 1,555,935 | 0 | 0 | 0 | For |
| Dimensional | 1,394,209 | 0 | 0 | 0 | For |
| TIAA | 1,382,693 | 0 | 0 | 0 | For |
| HARRIS ASSOCIATES INVESTMENT TRUST | 1,329,502 | 0 | 0 | 0 | For |
| Hartford | 1,197,876 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 1,144,770 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,080,718 | 0 | 0 | 0 | For |
| First Trust | 945,280 | 0 | 0 | 0 | For |
| John Hancock | 930,168 | 0 | 0 | 0 | For |
| GMO | 780,591 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 566,783 | 0 | 0 | 0 | For |
| AMCAP FUND | 523,858 | 0 | 0 | 0 | For |
| Victory Capital | 515,402 | 0 | 0 | 0 | For |
| Jackson National | 510,835 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 473,801 | 0 | 0 | 0 | For |
| JPMorgan | 466,391 | 0 | 0 | 0 | For |
Showing the 25 largest of 212 asset managers. All 212 are in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Susan D. DeVore
ELEVANCE HEALTH INC.’s own tally for this item (“Elect Director: Susan D. DeVore”): 185,839,586 for, 3,726,860 against, per its Form 8-K filed May 14, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2028 based on the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 212 asset managers below reported 71,525,400 for, 2,124,284 against, 23,052 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 21,455,590 | 2 | 0 | 0 | For |
| BlackRock | 7,179,332 | 0 | 0 | 0 | For |
| Fidelity | 5,329,206 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,546,451 | 3,247 | 0 | 0 | For |
| Capital Group | 4,089,010 | 0 | 0 | 0 | For |
| State Street | 2,438,236 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 2,437,343 | 0 | 0 | 0 | For |
| MFS | 0 | 1,828,454 | 0 | 0 | Against |
| Charles Schwab | 1,712,757 | 0 | 0 | 0 | For |
| Invesco | 1,555,935 | 0 | 0 | 0 | For |
| Dimensional | 1,394,209 | 0 | 0 | 0 | For |
| TIAA | 1,382,693 | 0 | 0 | 0 | For |
| HARRIS ASSOCIATES INVESTMENT TRUST | 1,329,502 | 0 | 0 | 0 | For |
| Hartford | 1,197,876 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 1,144,770 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,080,718 | 0 | 0 | 0 | For |
| First Trust | 945,280 | 0 | 0 | 0 | For |
| John Hancock | 930,168 | 0 | 0 | 0 | For |
| GMO | 780,591 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 566,783 | 0 | 0 | 0 | For |
| AMCAP FUND | 523,858 | 0 | 0 | 0 | For |
| Victory Capital | 515,402 | 0 | 0 | 0 | For |
| Jackson National | 510,835 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 473,801 | 0 | 0 | 0 | For |
| JPMorgan | 466,391 | 0 | 0 | 0 | For |
Showing the 25 largest of 212 asset managers. All 212 are in the interactive database (link above).
Combines 28 wordings of this item as funds reported it.
92% Approved · of votes cast
Prior year: 91.9% for (May 15, 2024 meeting) ▼ 0.1 pts
Description as filed by funds: Advisory vote to approve the compensation of our named executive officers.
ELEVANCE HEALTH INC.’s own tally for this item (“2. Advisory vote on the Company's executive compensation”): 173,964,580 for, 15,522,459 against — passed, per its Form 8-K filed May 14, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The advisory vote on the compensation of the Company's named executive officers was approved based upon the following votes:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of ELEVANCE HEALTH INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Compensation” (3 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 21,452,743 | 2,849 | 0 | 0 | For |
| BlackRock | 7,175,605 | 3,727 | 0 | 0 | For |
| Fidelity | 5,329,206 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,546,451 | 3,247 | 0 | 0 | For |
| Capital Group | 4,089,010 | 0 | 0 | 0 | For |
| State Street | 2,437,881 | 355 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 2,437,343 | 0 | 0 | 0 | For |
| MFS | 1,828,454 | 0 | 0 | 0 | For |
| Charles Schwab | 1,712,757 | 0 | 0 | 0 | For |
| Invesco | 1,555,935 | 0 | 0 | 0 | For |
| Dimensional | 1,394,209 | 0 | 0 | 0 | For |
| TIAA | 1,382,693 | 0 | 0 | 0 | For |
| HARRIS ASSOCIATES INVESTMENT TRUST | 1,329,502 | 0 | 0 | 0 | For |
| Hartford | 1,197,678 | 198 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 1,144,770 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,080,718 | 0 | 0 | 0 | For |
| First Trust | 945,280 | 0 | 0 | 0 | For |
| John Hancock | 930,168 | 0 | 0 | 0 | For |
| GMO | 780,591 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 566,783 | 0 | 0 | 0 | For |
| AMCAP FUND | 523,858 | 0 | 0 | 0 | For |
| Victory Capital | 515,402 | 0 | 0 | 0 | For |
| Jackson National | 510,835 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 473,801 | 0 | 0 | 0 | For |
| JPMorgan | 466,391 | 0 | 0 | 0 | For |
Fund voting reports, all 209 managers: 73,338,121 for, 353,867 against, 17,593 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,138,602 | 7,548 | 0 | 0 | For |
| T. Rowe Price | 9,132,476 | 12,299 | 0 | 0 | For |
| State Street | 6,474,590 | 355 | 0 | 0 | For |
| Wellington | 5,251,867 | 0 | 0 | 0 | For |
| Capital Group | 5,228,820 | 100 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 5,112,867 | 0 | 0 | 0 | For |
| Artisan | 3,102,425 | 0 | 0 | 0 | For |
| First Eagle Investment Management, LLC | 2,910,534 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2,699,040 | 0 | 0 | 0 | For |
| Sanders Capital, LLC | 2,601,433 | 0 | 0 | 0 | For |
| Orbis Allan Gray Ltd | 2,349,420 | 0 | 0 | 0 | For |
| Northern Trust | 2,052,277 | 0 | 0 | 0 | For |
| Nuveen | 1,935,226 | 0 | 0 | 0 | For |
| Invesco | 1,901,271 | 0 | 0 | 0 | For |
| HARRIS ASSOCIATES L P | 1,900,210 | 0 | 0 | 0 | For |
| Grantham, Mayo, Van Otterloo & Co. LLC | 1,869,670 | 0 | 0 | 0 | For |
| Charles Schwab | 1,743,987 | 0 | 0 | 0 | For |
| AllianceBernstein | 1,664,120 | 0 | 0 | 0 | For |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 1,628,432 | 0 | 0 | 0 | For |
| Brave Warrior Advisors, LLC | 0 | 1,602,021 | 0 | 0 | Against |
| Fidelity | 1,534,183 | 0 | 0 | 0 | For |
| John Hancock | 1,506,057 | 0 | 0 | 0 | For |
| UBS | 1,334,455 | 25,250 | 0 | 0 | For |
| EdgePoint Investment Group Inc. | 1,275,560 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL ADVISERS LLC | 1,192,648 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1,013 managers: 114,595,822 for, 11,614,645 against, 1,024 abstained, 54,930 not voted, 7,224 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
88% Approved · of votes cast
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025.
ELEVANCE HEALTH INC.’s own tally for this item (“3. Ratification of the appointment of Ernst & Young LLP”): 178,086,607 for, 23,455,317 against — passed, per its Form 8-K filed May 14, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2025 was ratified based upon the following votes:”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of ELEVANCE HEALTH INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (11 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
The 213 asset managers below reported 72,098,924 for, 1,422,064 against, 17,587 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,345,763 | 1,109,829 | 0 | 0 | Mixed |
| BlackRock | 7,179,332 | 0 | 0 | 0 | For |
| Fidelity | 5,329,206 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,549,698 | 0 | 0 | 0 | For |
| Capital Group | 4,089,010 | 0 | 0 | 0 | For |
| State Street | 2,438,200 | 36 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 2,437,343 | 0 | 0 | 0 | For |
| MFS | 1,828,454 | 0 | 0 | 0 | For |
| Charles Schwab | 1,712,757 | 0 | 0 | 0 | For |
| Invesco | 1,555,935 | 0 | 0 | 0 | For |
| Dimensional | 1,394,209 | 0 | 0 | 0 | For |
| TIAA | 1,382,693 | 0 | 0 | 0 | For |
| HARRIS ASSOCIATES INVESTMENT TRUST | 1,329,502 | 0 | 0 | 0 | For |
| Hartford | 1,197,678 | 198 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 1,144,770 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,080,718 | 0 | 0 | 0 | For |
| First Trust | 945,280 | 0 | 0 | 0 | For |
| John Hancock | 930,168 | 0 | 0 | 0 | For |
| GMO | 780,591 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 566,783 | 0 | 0 | 0 | For |
| AMCAP FUND | 523,858 | 0 | 0 | 0 | For |
| Victory Capital | 515,402 | 0 | 0 | 0 | For |
| Jackson National | 510,835 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 473,801 | 0 | 0 | 0 | For |
| JPMorgan | 466,391 | 0 | 0 | 0 | For |
Showing the 25 largest of 213 asset managers. All 213 are in the interactive database (link above).
Proposed by: John Chevedden and Laird Norton Family Foundation
Combines 9 wordings of this item as funds reported it.
14% Not approved · of votes cast
Description as filed by funds: Shareholder proposal requesting report on the effectiveness of Diversity, Equity and Inclusion efforts.
ELEVANCE HEALTH INC.’s own tally for this item (“4. Shareholder proposal requesting report on the effectiveness of Diversity, Equity and Inclusion efforts”): 26,240,205 for, 160,685,853 against — failed, per its Form 8-K filed May 14, 2025 (Item 5.07).
Reported outcome: Not approved, in the filing’s own words: “The shareholder proposal requesting a report on the effectiveness of Diversity, Equity, and Inclusion efforts was not approved based upon the following votes:”
Support: 14% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 214 asset managers below reported 2,688,391 for, 69,761,149 against, 1 withheld, 1,222,527 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 943,114 | 20,512,477 | 1 | 0 | Against |
| BlackRock | 4,668 | 7,174,664 | 0 | 0 | Against |
| Fidelity | 1,218 | 5,327,988 | 0 | 0 | Against |
| T. Rowe Price | 0 | 4,549,698 | 0 | 0 | Against |
| Capital Group | 0 | 4,089,010 | 0 | 0 | Against |
| State Street | 451 | 2,437,785 | 0 | 0 | Against |
| FIRST EAGLE FUNDS | 0 | 2,437,343 | 0 | 0 | Against |
| MFS | 0 | 1,828,454 | 0 | 0 | Against |
| Charles Schwab | 0 | 1,712,757 | 0 | 0 | Against |
| Invesco | 0 | 1,555,935 | 0 | 0 | Against |
| Dimensional | 0 | 1,394,209 | 0 | 0 | Against |
| TIAA | 0 | 1,382,693 | 0 | 0 | Against |
| HARRIS ASSOCIATES INVESTMENT TRUST | 0 | 1,329,502 | 0 | 0 | Against |
| Hartford | 198 | 1,197,678 | 0 | 0 | Against |
| FRANKLIN MUTUAL SERIES FUNDS | 0 | 1,144,770 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 0 | 1,080,718 | 0 | Abstain |
| First Trust | 0 | 945,280 | 0 | 0 | Against |
| John Hancock | 243,207 | 686,961 | 0 | 0 | Mixed |
| GMO | 0 | 780,591 | 0 | 0 | Against |
| INVESTMENT CO OF AMERICA | 0 | 566,783 | 0 | 0 | Against |
| AMCAP FUND | 0 | 523,858 | 0 | 0 | Against |
| Victory Capital | 0 | 515,402 | 0 | 0 | Against |
| Jackson National | 0 | 510,835 | 0 | 0 | Against |
| Bridge Builder Trust | 216,956 | 256,845 | 0 | 0 | Mixed |
| JPMorgan | 47 | 466,344 | 0 | 0 | Against |
Showing the 25 largest of 214 asset managers. All 214 are in the interactive database (link above).
Not shown here: this season’s fund filings also report 1 item from the meeting of May 15, 2024, which belongs to the 2023-2024 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 225,641,361 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 9.51% |
| 2 | BlackRock | 3.18% |
| 3 | Fidelity | 2.36% |
| 4 | T. Rowe Price | 2.02% |
| 5 | Capital Group | 1.81% |
| 6 | State Street | 1.08% |
| 7 | FIRST EAGLE FUNDS | 1.08% |
| 8 | MFS | 0.81% |
| 9 | Charles Schwab | 0.76% |
| 10 | Invesco | 0.69% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 4.05% |
| 2 | T. Rowe Price | 4.05% |
| 3 | State Street | 2.87% |
| 4 | Wellington | 2.33% |
| 5 | Capital Group | 2.32% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.27% |
| 7 | Artisan | 1.37% |
| 8 | First Eagle Investment Management, LLC | 1.29% |
| 9 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.20% |
| 10 | Sanders Capital, LLC | 1.15% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 21,311,015 | 9.44% | Form 13F, quarter ended March 31, 2025 |
| State Street | 10,647,703 | 4.72% | Form 13F, quarter ended March 31, 2025 |
| T. Rowe Price | 9,142,563 | 4.05% | Form 13F, quarter ended March 31, 2025 |
| Wellington Management | 5,794,794 | 2.57% | Form 13F, quarter ended March 31, 2025 |
| Morgan Stanley | 2,973,109 | 1.32% | Form 13F, quarter ended March 31, 2025 |
| Norges Bank | 2,719,804 | 1.21% | Form 13F, quarter ended March 31, 2025 |
| Northern Trust | 2,442,357 | 1.08% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 225,641,361 shares outstanding, as reported by ELEVANCE HEALTH INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At ELEVANCE HEALTH INC.'s shareholder meeting held May 14, 2025, in the 2024-2025 proxy season, 1,196 asset managers reported votes on at least one of its 6 ballot items in their SEC Form N-PX filings, covering 8,046 separate fund positions. On the most widely held item on that ballot — Advisory vote to approve the compensation of our named executive officers. — ELEVANCE HEALTH INC.'s filing reports the proposal as approved, with 92% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ELEVANCE HEALTH INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 14, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ELEVANCE HEALTH INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
ELEVANCE HEALTH INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “ELEVANCE HEALTH (ELV) 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/elevance-health-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.